Menu
Riseup-PPD
  • About
    • Action Structure
    • Action Members
    • Action Partners
  • Working Groups
    • Working Group 1
    • Working Group 2
    • Working Group 3
    • Working Group 4
    • Working Group 5
    • Working Group 6
      • Team
    • COVID-19 Taskforce
  • Activities
    • Status of Events
    • MC Meetings
    • Training Schools
    • Workshops
    • ITC conference Grants
    • Virtual Networking Tools
    • International Conference 2023
    • International Conference 2022
      • Programme
      • Speakers
  • Calls
  • Dissemination
    • Research Publications
    • Presentations
    • Publication Guidelines
    • Press
    • Newsletter
    • Flyer
  • Contact
  • About
    • Action Structure
    • Action Members
    • Action Partners
  • Working Groups
    • Working Group 1
    • Working Group 2
    • Working Group 3
    • Working Group 4
    • Working Group 5
    • Working Group 6
      • Team
    • COVID-19 Taskforce
  • Activities
    • Status of Events
    • MC Meetings
    • Training Schools
    • Workshops
    • ITC conference Grants
    • Virtual Networking Tools
    • International Conference 2023
    • International Conference 2022
      • Programme
      • Speakers
  • Calls
  • Dissemination
    • Research Publications
    • Presentations
    • Publication Guidelines
    • Press
    • Newsletter
    • Flyer
  • Contact

Background

The implementation of the Action is organized in six interdisciplinary WGs, responsible for developing the activities that will be ultimately defined by the MC and accepted by the COST Members in the Memorandum of Understanding. In particular, WG1 focuses on prevention and clinical interventions for PPD (evidence-based and new approaches), and its socioeconomic impact. WGs 2 and 3 will study of psychological assessment, genetic and epigenetic biomarkers and neuroimaging and neurophysiological assessment tools, and WG 4 aims at exploring the ethical specifications for research in PPD. WG 5 aims at working on the best data management and analysis strategies, and WG 6 at ensuring both a good visibility of the results and effective knowledge transfer. Members from different sectors and heterogeneous backgrounds will compose each WG, to allow the implementation of multidisciplinary efforts to drive the Action plans.
WG1: Prevention and Treatment strategies in PPD

WG2: Assessment approaches and methods in PPD

WG3: Neuroimaging and neurophysiological data acquisition and analysis in PPD

WG4: Ethical standards and procedures for clinical research in PPD

WG5: Data sharing and data management in PPD

WG6: Inclusiveness, Dissemination and Public Engagement​
Powered by Create your own unique website with customizable templates.